These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26289556)

  • 21. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
    Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
    Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
    Sumazin P; Peters TL; Sarabia SF; Kim HR; Urbicain M; Hollingsworth EF; Alvarez KR; Perez CR; Pozza A; Najaf Panah MJ; Epps JL; Scorsone K; Zorman B; Katzenstein H; O'Neill AF; Meyers R; Tiao G; Geller J; Ranganathan S; Rangaswami AA; Woodfield SE; Goss JA; Vasudevan SA; Heczey A; Roy A; Fisher KE; Alaggio R; Patel KR; Finegold MJ; López-Terrada DH
    J Hepatol; 2022 Oct; 77(4):1026-1037. PubMed ID: 35577029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimen.
    Sakairi T; Kobayashi K; Goto K; Okada M; Kusakabe M; Tsuchiya T; Sugimoto J; Sano F; Mutai M
    Toxicol Pathol; 2001; 29(4):479-82. PubMed ID: 11560253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma.
    Wang H; Lu J; Edmunds LR; Kulkarni S; Dolezal J; Tao J; Ranganathan S; Jackson L; Fromherz M; Beer-Stolz D; Uppala R; Bharathi S; Monga SP; Goetzman ES; Prochownik EV
    J Biol Chem; 2016 Dec; 291(51):26241-26251. PubMed ID: 27738108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma.
    Inui Y; Higashiyama S; Kawata S; Tamura S; Miyagawa J; Taniguchi N; Matsuzawa Y
    Gastroenterology; 1994 Dec; 107(6):1799-804. PubMed ID: 7958694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
    Castven D; Fischer M; Becker D; Heinrich S; Andersen JB; Strand D; Sprinzl MF; Strand S; Czauderna C; Heilmann-Heimbach S; Roessler S; Weinmann A; Wörns MA; Thorgeirsson SS; Galle PR; Matter MS; Lang H; Marquardt JU
    Oncotarget; 2017 Jul; 8(30):48688-48700. PubMed ID: 28415775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clear cell hepatocellular carcinoma arising 25 years after the successful treatment of an infantile hepatoblastoma.
    Basile J; Caldwell S; Nolan N; Hammerle C
    Ann Hepatol; 2010; 9(4):465-7. PubMed ID: 21057168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcomatoid hepatocellular carcinoma with hepatoblastoma-like features in an adult.
    Cho MS; Lee SN; Sung SH; Han WS
    Pathol Int; 2004 Jun; 54(6):446-50. PubMed ID: 15144405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
    Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
    J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative genomic analysis of mouse and human hepatocellular carcinoma.
    Dow M; Pyke RM; Tsui BY; Alexandrov LB; Nakagawa H; Taniguchi K; Seki E; Harismendy O; Shalapour S; Karin M; Carter H; Font-Burgada J
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9879-E9888. PubMed ID: 30287485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
    Kim Y; Sills RC; Houle CD
    Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatoblastomas in mice in the US National Toxicology Program (NTP) studies.
    Turusov VS; Torii M; Sills RC; Willson GA; Herbert RA; Hailey JR; Haseman JK; Boorman GA
    Toxicol Pathol; 2002; 30(5):580-91. PubMed ID: 12371667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
    Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
    Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of expression profiling of early-stage carcinogenesis using nodule-in-nodule-type hepatocellular carcinoma.
    Nam SW; Lee JH; Noh JH; Lee SN; Kim SY; Lee SH; Park CK; Ahn YM; Park WS; Yoo NJ; Lee JY
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):239-47. PubMed ID: 16462536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver.
    Zogopoulos G; Albrecht S; Pietsch T; Alpert L; von Schweinitz D; Lefèbvre Y; Goodyer CG
    Cancer Res; 1996 Jul; 56(13):2949-53. PubMed ID: 8674047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.
    Kaposi-Novak P; Lee JS; Gòmez-Quiroz L; Coulouarn C; Factor VM; Thorgeirsson SS
    J Clin Invest; 2006 Jun; 116(6):1582-95. PubMed ID: 16710476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
    Qiu W; David D; Zhou B; Chu PG; Zhang B; Wu M; Xiao J; Han T; Zhu Z; Wang T; Liu X; Lopez R; Frankel P; Jong A; Yen Y
    Am J Pathol; 2003 Jun; 162(6):1961-74. PubMed ID: 12759252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale sequencing analysis of the full-length cDNA library of human hepatocellular carcinoma.
    Tsai CC; Chung YD; Lee HJ; Chang WH; Suzuku Y; Sugano S; Lin JY
    J Biomed Sci; 2003; 10(6 Pt 1):636-43. PubMed ID: 14576466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.